Two novel piperidones induce apoptosis and antiproliferative effects on human prostate and lymphoma cancer cell lines.
Autor: | Swain, Risa Mia, Contreras, Lisett, Varela-Ramirez, Armando, Hossain, Mohammad, Das, Umashankar, Valenzuela, Carlos A., Penichet, Manuel L., Dimmock, Jonathan R., Aguilera, Renato J |
---|---|
Předmět: |
FLOW cytometry
WESTERN immunoblotting ORGANIC compounds APOPTOSIS ANTINEOPLASTIC agents COLORECTAL cancer T-test (Statistics) CELL proliferation HEMATOLOGIC malignancies STATISTICAL hypothesis testing CELL lines LYMPHOMAS MOLECULAR structure REACTIVE oxygen species DATA analysis software PROSTATE tumors MEMBRANE potential CASPASES PHARMACODYNAMICS |
Zdroj: | Investigational New Drugs; Oct2022, Vol. 40 Issue 5, p905-921, 17p |
Abstrakt: | Summary: Cancer remains the second most common cause of death in the US. Due to a recurrent problem with anticancer drug resistance, there is a current need for anticancer drugs with distinct modes of action for combination drug therapy We have tested two novel piperidone compounds, named 2608 (1-dichloroacetyl − 3,5-bis(3,4-difluorobenzylidene)-4-piperidone) and 2610 (1-dichloroacetyl-3,5-bis(3,4-dichlorobenzylidene)-4-piperidone), for their potential cytotoxicity on numerous human cancer cell lines. We found that both compounds were cytotoxic for breast, pancreatic, leukemia, lymphoma, colon, and fibroblast cell lines, with a cytotoxic concentration 50% (CC |
Databáze: | Complementary Index |
Externí odkaz: |